Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Carl Icahn’s Best Activist Campaigns To Imitate

Activist investing has gained a considerable amount of traction among retail investors for the last couple of years, whereby the trend is to follow renowned activists like Carl Icahn of Icahn Capital LP as they take a sizable position in the companies that they seek to transform. The followers into the stock can simply ride the wagon and reap the value that is created in the wake of the activism. In 2014 alone there were a total of 344 activist campaigns, compared to about 291 in 2013 and less than 30 back in 2000. One long-only event driven fund that follows around 30 activist campaigns at any given time is Kenneth Squire‘s 13D Management. We decided to cross-match the fund’s top holdings against those of one of the best in the activist business, Carl Icahn. Our list includes Hologic, Inc. (NASDAQ:HOLX), Hertz Global Holdings Inc (NYSE:HTZ), Gannett Co., Inc. (NYSE:GCI), Nuance Communications Inc. (NASDAQ:NUAN), Chesapeake Energy Corporation (NYSE:CHK), and Manitowoc Company Inc (NYSE:MTW).

Carl Icahn as viking

Following activist funds like Icahn Capital is important because it is a very specific and focused strategy in which the investor doesn’t have to wait for catalysts to realize gains in the holding. A fund like Icahn Capital can simply create its own catalysts by pushing for them through negotiations with the company’s management and directors. In recent years, the average returns of activists’ hedge funds has been much higher than the returns of an average hedge fund. Furthermore, we believe do-it-yourself investors have an advantage over activist hedge fund investors because they don’t have to pay 2% of their assets and 20% of their gains every year to compensate hedge fund managers. We have found through extensive research that the top small-cap picks of hedge funds are also capable of generating high returns and built a system around this premise. In the 32 months since our small-cap strategy was launched it has returned over 144% and beaten the S&P 500 ETF (SPY) by more than 84 percentage points (read more details). Soon, we’ll be releasing a new quarterly newsletter written by former activist hedge fund analyst Michael Bland that tracks ten or so activist campaigns at any given time.

Carl Icahn
Carl Icahn
Icahn Capital LP

Icahn, the legendary corporate raider, recently decided to return $1.76 billion back to investors. However he is not leaving the investment world, as he plans to invest his own money. The market value of his fund’s public equity portfolio stood at $32.05 billion at the end of March. 13D on the other hand is a much smaller player, with about $375 million worth of regulatory assets under management, but it is the fund’s strategy that makes it unique. Founded in 2011, 13D manages one main fund broken into three share classes, which has delivered an average annual return of over 23% since its inception, showcasing the validity of following activist campaigns.

Both Icahn Capital and 13D added Hologic, Inc. (NASDAQ:HOLX) to their portfolios in the last quarter of 2013. The $10.75 billion developer and manufacturer of health care diagnostic testing products, imaging systems and surgical products had shown a profit in only one of the last six years before Icahn took a stake in the company. At the end of its fiscal year 2014, Hologic, Inc. (NASDAQ:HOLX) turned in a total profit of $17.3 million. Icahn’s stake in the company represents 12.16% of the company’s outstanding shares and amounts to 34.15 million shares valued at $1.13 billion, while 13D’s stake comprises 468,800 shares valued at $15.48 million. After Icahn, another prominent activist investor, Ralph V. Whitworth‘s Relational Investors is the largest stockholder of Hologic, Inc. (NASDAQ:HOLX) within our database, owning some 12.97 million shares valued at $428.28 million.

The second company on our list,  Hertz Global Holdings Inc (NYSE:HTZ), caught Icahn’s eye in the third quarter of 2014 as he felt that the company was undervalued and hence took an activist stake in the $9.39 billion car rental business. The company’s stock has slid by more than 26% since then amid accounting issues plaguing it that not even Icahn has been able to overcome thus far. The management of Hertz Global Holdings Inc (NYSE:HTZ) expect to release their first quarter financial results along with the restated ones for the last three years by the middle of this year. The rental & leasing services industry has been showing weakness this year as well, and is down by nearly 2%. Icahn’s stake in Hertz stood at 51.92 million shares valued at $1.13 billion at the end of March, while 13D increased its stake in Hertz Global Holdings Inc (NYSE:HTZ) by 19% during the first quarter to about 529,200 shares valued at $11.45 million. Yet another big activist, Barry Rosenstein‘s JANA Partners, is the second-largest stockholder after Icahn among those that we track, owning some 41.78 million shares of Hertz Global Holdings Inc (NYSE:HTZ) valued at $905.82 million.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.